John Libbey Eurotext

Magnesium Research

Magnesium in the CNS: recent advances and developments Volume 29, numéro 3, September 2016

  • [1] Vink R, Nechifor M, eds. Magnesium In The Central Nervous System. 2012; Adelaide: Adelaide University Press.
  • [2] Vink R., Mcintosh T.K., Demediuk P., Weiner M.W., Faden A.I. Decline in intracellular free Mg is associated with irreversible tissue injury after brain trauma. J Biol Chem. 1988;263:757-761. 2+
  • [3] Vink R., Cernak I. Regulation of intracellular free magnesium in central nervous system injury. Front Biosci. 2000;5:D656-D665.
  • [4] Vink R., Mcintosh T.K. Pharmacological and physiological effects of magnesium on experimental traumatic brain injury. Magnes Res. 1990;3:163-169.
  • [5] Vink R., Donkin J.J., Cruz M.I., Nimmo A.J., Cernak I. A substance P antagonist increases brain intracellular free magnesium concentration after diffuse traumatic brain injury in rats. J Am Coll Nutr. 2004;23:538S-540S.
  • [6] Sen A.P., Gulati A. Use of magnesium in traumatic brain injury. Neurotherapeutics. 2010;7:91-99.
  • [7] Dhandapani S.S., Gupta A., Vivekanandhan S., Sharma B.S., Mahapatra A.K. Randomized controlled trial of magnesium sulphate in severe closed traumatic brain injury. Ind J Neurotrauma. 2008;5:27-33.
  • [8] Temkin N.R., Anderson G.D., Winn H.R. Magnesium sulfate for neuroprotection after traumatic brain injury: A randomised controlled trial. Lancet Neurol. 2007;6:29-38.
  • [9] Heath D.L., Vink R. Optimization of magnesium therapy after severe diffuse axonal brain injury in rats. J Pharmacol Exp Ther. 1999;288:1311-1316.
  • [10] O’Connor C.A., Cernak I., Vink R. The temporal profile of edema formation differs between male and female rats following diffuse traumatic brain injury. Acta Neurochir Suppl. 2006;96:121-124.
  • [11] Brewer R.P., Parra A., Borel C.O., Hopkins M.B., Reynolds J.D. Intravenous magnesium sulfate does not increase ventricular csf ionized magnesium concentration of patients with intracranial hypertension. Clin Neuropharmacol. 2001;24:341-345.
  • [12] Stippler M., Fischer M.R., Puccio A.M. Serum and cerebrospinal fluid magnesium in severe traumatic brain injury outcome. J Neurotrauma. 2007;24:1347-1354.
  • [13] Milton Harris J., Martin N.E., Modi M. Pegylation: A novel process for modifying pharmacokinetics. Clin Pharmacokinet. 2001;40:539-551.
  • [14] Ditor D.S., John S.M., Roy J., Marx J.C., Kittmer C., Weaver L.C. Effects of polyethylene glycol and magnesium sulfate administration on clinically relevant neurological outcomes after spinal cord injury in the rat. J Neurosci Res. 2007;85:1458-1467.
  • [15] Kwon B.K., Roy J., Lee J.H. Magnesium chloride in a polyethylene glycol formulation as a neuroprotective therapy for acute spinal cord injury: Preclinical refinement and optimization. J Neurotrauma. 2009;26:1379-1393.
  • [16] Busingye D.S., Turner R.J., Vink R. Combined magnesium/polyethylene glycol facilitates the neuroprotective effects of magnesium in traumatic brain injury at a reduced magnesium dose. CNS Neurosci Ther. 2016;22:854-859.
  • [17] Flink E.B. Magnesium deficiency in alcoholism. Alcohol Clin Exp Res. 1986;10:590-594.
  • [18] Mullins P.G.M., Vink R. Chronic alcohol exposure decreases brain intracellular free magnesium concentration in rats. Neuroreport. 1995;6:1633-1636.
  • [19] Ema M., Gebrewold A., Altura B.T., Zhang A.M., Altura B.M. Alcohol-induced vascular damage of brain is ameliorated by administration of magnesium. Alcohol. 1998;15:95-103.
  • [20] Vink R., Byard R.W. Alcohol intoxication may exacerbate the effects of blunt cranial trauma through changes in brain free magnesium levels. J Forensic Sci. 2012;57:979-982.
  • [21] Mcintosh T.K., Faden A.I., Yamakami I., Vink R. Magnesium deficiency exacerbates and pretreatment improves outcome following traumatic brain injury in rats: 31P magnetic resonance spectroscopy and behavioral studies. J Neurotrauma. 1988;5:17-31.
  • [22] Kodikara S. A death due to concussive brain injury augmented by alcohol. Forensic Sci Med Pathol. 2007;3:283-284.
  • [23] Marinov M.B., Harbaugh K.S., Hoopes P.J., Pikus H.J., Harbaugh R.E. Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia. J. Neurosurgery. 1996;85:117-124.
  • [24] Westermaier T., Hungerhuber E., Zausinger S., Baethmann A., Schmid-Elsaesser R. Neuroprotective efficacy of intra-arterial and intravenous magnesium sulfate in a rat model of transient focal cerebral ischemia. Acta Neurochir Suppl. 2003;145:393-399.
  • [25] Muir K.W., Lees K.R., Ford I., Davis S. Magnesium for acute stroke (intravenous magnesium efficacy in stroke trial): Randomised controlled trial. Lancet. 2004;363:439-445.
  • [26] Aslanyan S., Weir C.J., Muir K.W., Lees K.R. Magnesium for treatment of acute lacunar stroke syndromes: Further analysis of the images trial. Stroke. 2007;38:1269-1273.
  • [27] Saver J.L., Starkman S., Eckstein M. Investigators F-M Coordinators. Prehospital use of magnesium sulfate as neuroprotection in acute stroke. N Engl J Med. 2015;372:528-536.
  • [28] Chui D, Chen Z, Yu J, et al. Magnesium in alzheimer's disease. In: Magnesium in the Central Nervous System, R. Vink and M. Nechifor, eds, 2011, Adelaide: Adelaide University Press, 239-250.
  • [29] Li W., Yu J., Liu Y. Elevation of brain magnesium prevents synaptic loss and reverses cognitive deficits in alzheimer's disease mouse model. Mol Brain. 2014;7:65.
  • [30] Jia S., Liu Y., Shi Y. Elevation of brain magnesium potentiates neural stem cell proliferation in the hippocampus of young and aged mice. J Cell Physiol. 2016;231:1903-1912.
  • [31] Jia S., Mou C., Ma Y., Han R., Li X. Magnesium regulates neural stem cell proliferation in the mouse hippocampus by altering mitochondrial function. Cell Biol Int. 2016;40:465-471.
  • [32] Corrigan F., Vink R., Blumbergs P.C. SAPPalpha rescues deficits in amyloid precursor protein knockout mice following focal traumatic brain injury. J Neurochem. 2012;122:208-220.
  • [33] Van Den Heuvel C., Finnie J.W., Blumbergs P.C. Upregulation of neuronal amyloid precursor protein (APP) and APP mRNA following magnesium sulphate (MgSO) therapy in traumatic brain injury. J Neurotrauma. 2000;17:1041-1053. 4
  • [34] Nimmo AJ, Vink R. Recent patents in CNS drug discovery: The management of inflammation in the central nervous system. Recent Pat CNS Drug Discov 2009; 4:86-95.
  • [35] Corrigan F., Vink R., Turner R.J. Inflammation in acute cns injury: A focus on the role of substance P. Br J Pharmacol. 2016;173:703-715.
  • [36] Richardson J.D., Vasko M.R. Cellular mechanisms of neurogenic inflammation. J Pharmacol Exp Ther. 2002;302:839-845.
  • [37] Mazur A., Maier JaM, Rock E., Gueux E., Nowacki W., Rayssiguier Y. Magnesium and the inflammatory response: Potential physiopathological implications. Arch Biochem Biophys. 2006;458:48-56.
  • [38] Dibaba D.T., Xun P., He K. Dietary magnesium intake is inversely associated with serum c-reactive protein levels: Meta-analysis and systematic review. Eur J Clin Nutr. 2014;68:510-516.
  • [39] Weglicki W.B., Phillips T.M. Pathobiology of magnesium deficiency: A cytokine/neurogenic inflammation hypothesis. Am J Physiol. 1992;263:R734-R737.
  • [40] Kramer J.H., Phillips T.M., Weglicki W.B. Magnesium-deficiency-enhanced post-ischemic myocardial injury is reduced by substance P receptor blockade. J Mol Cell Cardiol. 1997;29:97-110.
  • [41] Donkin J.J., Turner R.J., Hassan I., Vink R. Substance P in traumatic brain injury. Prog Brain Res. 2007;161:97-109.
  • [42] Nimmo A.J., Cernak I., Heath D.L., Hu X., Bennett C.J., Vink R. Neurogenic inflammation is associated with development of edema and functional deficits following traumatic brain injury in rats. Neuropeptides. 2004;38:40-47.